Most appropriate marker of GIST-
A. CD117
B. CD 34
C. CK
D. Vimentin
Ans. A. CD117
Gastrointestinal stromal tumor
1. A gastrointestinal stromal tumor GIST.
is one of the most common mesenchymal tumors
of the gastrointestinal tract 1-3%
of all gastrointestinal malignancies. . They are typically defined as tumors
whose behavior is drrven by mutations in the Kit g or PDGFRA gene,
and may or may not stain positively for Kit.
Signs and symptoms
2.
Patients present with dysphagia, GIT hemorrhage or metastases mainly in the
liver. . Intestinal obstruction is rare, due to the tumor’s outward pattern of
growth.
3. Generally, the definitive diagnosis is made with a
biopsy, which can be obtained endoscopically,
percutaneously with CT or ultrasound guidance or at the time of surgery.
4. When GIST is suspected—as opposed to other causes for similar tumors—the
pathologist can
useimmunohistochemistrv specific antibodies that stain the
molecule CD 117 also known as c-kit.
95% of all GISTs are CD 117-positive other possible markers include
CD34, desmin, vimentin and
others. . Other cells that show CD 117 positivity are mast cells.
If the CD117 stain is negative and suspicion remains that the tumor is a GIST,
the newer antibody
DOG-i Discovered On GIST-i. can be used.
Also sequencing of Kit and PDGFRA can be used to prove
the diagnosis.
5. Pathophysiology
GISTs are tumors of connective tissue, i.e.sarcomas unlike most
gastrointestinal tumors, they are
non-epithelial.
6. GISTs are thought to arise from interstitial cells of Cajal ICC. ,
that are normally part of
the autonomic nervous system of the intestine. They serve a pacemaker
function in
controlling motility.
7. Most 50-80%. GISTs arise because of a
mutation in a called c-kit. This
gene encodes
a transmembrane receptor for a growth factor termed scf stem cell factor. . The c-kit/CD 117 receptor is
expressed on ICCs and a large number of other cells, mainly bone marrow cells,mast
cells, melanocytes and several others. In the gut, however, a mass
staining positive for CD117 is likely
to be a GIST, arising from ICC cells.
8. The c-kit molecule comprises
a long extracellular domain, a transmembrane segment, and an
intracellular part. Mutations generally occur in the DNA encoding the
intracellular part exon 11. ,
which acts as a tyrosine kinase to activate other enzymes.
9. The tyrosine kinase function of c-kit is vital in the therapy for GISTs.
10. Therapy Surgery is the mainstay of therapy for non-metastatic GISTs.
The c-kit tyrosine kinase
inhibitor imatinib is used
CD34 molecule is a cluster of differentiation molecule present on
certain cells within the human body. It is a cell surface glycoprotein and
functions as a cell-cell adhesion factor.
It may also mediate the attachment of stem
cells to bone marrow extracellular matrix or directly to stromal
cells.
No comments:
Post a Comment